InvestorsHub Logo
Followers 3
Posts 178
Boards Moderated 0
Alias Born 04/03/2016

Re: Mrblabla post# 25549

Thursday, 07/18/2019 11:44:03 AM

Thursday, July 18, 2019 11:44:03 AM

Post# of 27627
The latest PR was confirmation that Dr. Randy Purves has earned his stock options.

Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development. Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ?9-tetrahydrocannabinol (“THC”) analyte capture from human breath. THC is found in breath in generally low quantities. The Company has significantly improved sample collection methods using the breath collection unit (“BCU”) and other newly developed techniques.



A primary interest of Dr. Purves is to use his expertise in FAIMS and small molecule analysis to improve quantification methods of analytes in challenging matrices.



https://www.globenewswire.com/news-release/2019/07/15/1882702/0/en/Cannabix-Technologies-Makes-Advances-with-Marijuana-Breathalyzer-Development-and-THC-Breath-Capture.html

https://www.globenewswire.com/news-release/2019/05/13/1822501/0/en/Cannabix-Technologies-Adds-Dr-Randall-Purves-as-Scientific-Advisor.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News